Deutsche Bank Ag\ Kezar Life Sciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 279,265 shares of KZR stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

279,265

Previous 279,265 -0.0%

Holding current value

$2.08 Million

Previous $167,000 28.74%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.15 $167,922 - $268,209	233,226 Added 506.58%	279,265 $265,000
Q3 2023 Nov 09, 2023	SELL	$1.08 - $2.54 $306,079 - $719,853	-283,407 Reduced 86.03%	46,039 $54,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $15,853 - $21,000	6,863 Added 2.13%	329,446 $807,000
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $46,602 - $108,838	14,889 Added 4.84%	322,583 $1.01 Million
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $40,768 - $56,144	6,380 Added 2.12%	307,694 $2.17 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $471 - $634	59 Added 0.02%	301,314 $2.59 Million
Q2 2022 Aug 11, 2022	BUY	$4.58 - $17.13 $12,118 - $45,325	2,646 Added 0.89%	301,255 $2.49 Million
Q1 2022 May 13, 2022	SELL	$12.3 - $18.33 $27,994 - $41,719	-2,276 Reduced 0.76%	298,609 $4.96 Million
Q4 2021 Feb 11, 2022	SELL	$7.44 - $16.72 $3.65 Million - $8.2 Million	-490,651 Reduced 61.99%	300,885 $5.03 Million
Q3 2021 Nov 04, 2021	SELL	$4.85 - $9.73 $237 - $476	-49 Reduced 0.01%	791,536 $6.84 Million
Q2 2021 Aug 11, 2021	BUY	$4.93 - $6.46 $3.8 Million - $4.98 Million	771,213 Added 3785.65%	791,585 $4.3 Million
Q1 2021 May 13, 2021	SELL	$5.24 - $6.99 $9,966 - $13,294	-1,902 Reduced 8.54%	20,372 $121,000
Q4 2020 Feb 16, 2021	BUY	$4.77 - $6.58 $31,400 - $43,316	6,583 Added 41.95%	22,274 $116,000
Q3 2020 Nov 12, 2020	BUY	$4.36 - $5.5 $13,947 - $17,594	3,199 Added 25.61%	15,691 $76,000
Q2 2020 Aug 13, 2020	SELL	$3.6 - $7.75 $38,451 - $82,777	-10,681 Reduced 46.09%	12,492 $65,000
Q1 2020 May 14, 2020	SELL	$2.77 - $5.75 $20,270 - $42,078	-7,318 Reduced 24.0%	23,173 $101,000
Q4 2019 Feb 14, 2020	BUY	$2.5 - $4.26 $15,262 - $26,007	6,105 Added 25.03%	30,491 $121,000
Q3 2019 Nov 14, 2019	BUY	$3.0 - $7.58 $39,255 - $99,184	13,085 Added 115.79%	24,386 $78,000
Q2 2019 Aug 14, 2019	SELL	$7.09 - $21.9 $34,095 - $105,317	-4,809 Reduced 29.85%	11,301 $85,000
Q1 2019 May 15, 2019	BUY	$16.83 - $23.75 $157,158 - $221,777	9,338 Added 137.89%	16,110 $285,000
Q4 2018 Feb 14, 2019	SELL	$20.21 - $32.9 $98,826 - $160,881	-4,890 Reduced 41.93%	6,772 $159,000
Q3 2018 Dec 21, 2021	BUY	$15.5 - $21.41 $21,049 - $29,074	1,358 Added 13.18%	11,662 $249,000
Q3 2018 Nov 14, 2018	BUY	$15.5 - $21.41 $159,712 - $220,608	10,304 New	10,304 $220,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $510M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account